The role of sphingosine kinases/sphingosine-1-phosphate dependent signaling in mice brains exposed to type II diabetes mellitus and high-fat diet. Searching for potential neuroprotective effects of fingolimod and metformin.

2018/29/N/NZ4/00616

Keywords

Descriptors

  • NZ4_11: Metabolizm
  • NZ4_9: Neurobiologia systemowa
  • NZ3_7: Przekaźnictwo sygnału

Panel

NZ4 – Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology

Host institution

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Przemysław Leonard Wencel

Number of co-investigators in the project: 2

Call

PRELUDIUM 15 – announced on 2018-03-15

Amount awarded
209 940 PLN
Project start date
2019-01-31
Project end date
2023-01-30
Project duration
48 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. Glukometr. Cost: 300 PLN

Information in the final report

Publication in academic press/journals (1)

  1. Fingolimod Modulates the Gene Expression of Proteins Engaged in Inflammation and Amyloid-Beta Metabolism and Improves Exploratory and Anxiety-Like Behavior in Obese Mice

    Authors:
    Przemyslaw Leonard Wencel, Kamilla Blecharz-Klin, Agnieszka Piechal, Justyna Pyrzanowska, Dagmara Mirowska-Guzel, Robert Piotr Strosznajder
    Academic press:
    Neurotherapeutics (year: 2023, volume: online, pages: 46039), Publisher: Springer Nature
    Status:
    Published
    DOI:
    10.1007/s13311-023-01403-2 – link to the publication

Articles in post-conference publications (4)

  1. Fingolimod exerts anxiolytic effect and upregulates genes involved in neuronal survival and amyloid beta metabolism in diabetic mice hippocampus

    Authors:
    Przemysław Wencel, Kamilla Blecharz-Klin, Magdalena Świerczyńska, Agnieszka Piechal, Justyna Pyrzanowska, Dagmara Mirowska-Guzel, Robert Piotr Strosznajder
    Conference:
    34 th ECNP Congress, Hybrid (year: 2021, pages: S396-S397), Publisher: Elsevier, European Neuropsychopharmacology, Volume 53, Supplement 1
    Date:
    conference 2-5 October 2021
    Status:
    Published
  2. Fingolimod modulates genes expression of sphingosine-1-phoshate receptors and Sirt1 in diabetic mice brain

    Authors:
    Przemyslaw Wencel, Robert Piotr Strosznajder
    Conference:
    33rd ECNP Congress Virtual (year: 2020, pages: S407-S408), Publisher: European Neuropsychopharmacology, Elsevier
    Date:
    conference 12-15 września 2020
    Status:
    Published
  3. Metformin modulates gene expression of inflammatory proteins and sphingosine kinase 2 in diabetic mice hippocampus

    Authors:
    Przemysław Leonard Wencel, Robert Piotr Strosznajder
    Conference:
    Neuropatologia Neuroscience (year: 2021, pages: 432), Publisher: Termedia, Folia Neuropathologica 2021; 59/4
    Date:
    conference 19 November, 2021
    Status:
    Published
  4. Anti-inflammatory role of metformin in brain cortex of pre-diabetic obese mice

    Authors:
    Przemyslaw Wencel, Robert Piotr Strosznajder
    Conference:
    35th ECNP Congress 2022 (year: 2022, pages: 123), Publisher: Elsevier, Neuroscience Applied
    Date:
    conference 15-18 October 2022
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski